Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MICRON SOLUTIONS INC /DE/Financial_Report.xls
EX-31.2 - EXHIBIT - MICRON SOLUTIONS INC /DE/ex31210qsept2012cfo.htm
EX-32.1 - EXHIBIT - MICRON SOLUTIONS INC /DE/ex32110qsept2012ceo.htm
EX-31.1 - EXHIBIT - MICRON SOLUTIONS INC /DE/ex31110qsept2012ceo.htm
10-Q - 10-Q - MICRON SOLUTIONS INC /DE/hrt10-q09302012.htm


Exhibit 32.2



CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Arrhythmia Research Technology, Inc. (the “Company”) for the quarter ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Executive Vice President and Chief Financial Officer certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 

(1)
 The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date: November 21, 2012
 
/s/ David A. Garrison
David A. Garrison
Executive Vice President
and Chief Financial Officer